![Sandra J. Gunselman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sandra J. Gunselman
Directeur Général chez Mobility Health, Inc.
Postes actifs de Sandra J. Gunselman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Assurex Health, Inc.
![]() Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Corporate Officer/Principal | 29/06/2015 | - |
Mobility Health, Inc. | Directeur Général | 01/01/2020 | - |
Fondateur | 01/01/2020 | - | |
President | 01/01/2020 | - |
Historique de carrière de Sandra J. Gunselman
Formation de Sandra J. Gunselman
Lipscomb University | Undergraduate Degree |
Colorado State University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Assurex Health, Inc.
![]() Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
Mobility Health, Inc. |
- Bourse
- Insiders
- Sandra J. Gunselman
- Expérience